ACHILLION PHARMACEUTICALS INC (ACHN) is a publicly traded company in the Unknown sector. Across all available filings, 54 corporate insiders have executed 539 transactions totaling $411.0M, demonstrating a bearish sentiment with -$250.7M in net insider flow. The most recent transaction on Jan 28, 2020 involved a transaction of 90,000 shares valued at $567.0K.
No significant insider buying has been recorded for ACHN in the recent period.
No significant insider selling has been recorded for ACHN in the recent period.
Based on recent SEC filings, insider sentiment for ACHN is bearish with an Insider Alignment Score of 19/100 and a net flow of -$250.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ACHILLION PHARMACEUTICALS INC (ACHN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 54 insiders are actively trading ACHN stock, having executed 539 transactions in the past 90 days. The most active insider is Capital Management, Llc Ra (Executive), who has made 55 transactions totaling $102.9M.
Get notified when executives and directors at ACHN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 28, 2020 | S. Fisherman Jason | Executive | Disposition | 90,000 | $6.30 | $567.0K | Large |
| Jan 28, 2020 | S. Fisherman Jason | Executive | Disposition | 1,500 | $6.30 | $9.4K | |
| Jan 28, 2020 | Graves Kurt | Executive | Disposition | 22,709 | $6.30 | $143.1K | |
| Jan 28, 2020 | E. Manning Martha | Executive | Disposition | 2,500 | $6.30 | $15.8K | |
| Jan 28, 2020 | Scheer David | Executive | Disposition | 63,249 | $6.30 | $398.5K | |
| Jan 28, 2020 | Scheer David | Executive | Disposition | 29,515 | $6.30 | $185.9K | |
| Jan 28, 2020 | Truitt Joseph | Executive | Disposition | 3,500 | $6.30 | $22.1K | |
| Jan 28, 2020 | Robert L. Van Nostrand | Executive | Disposition | 40,000 | $6.30 | $252.0K | |
| Jan 28, 2020 | Vitullo Nicole | Executive | Disposition | 25,159 | $6.30 | $158.5K | |
| Jan 28, 2020 | Vitullo Nicole | Executive | Disposition | 36,431 | $6.30 | $229.5K | |
| Jan 28, 2020 | Vitullo Nicole | Executive | Disposition | 3,393,382 | $6.30 | $21.4M | Large |
| Jan 28, 2020 | Llc Susquehanna Securities, | Executive | Other | 14,115,498 | $6.30 | $88.9M | Large |
| Jan 28, 2020 | Llc Susquehanna Securities, | Executive | Other | 10,917 | $6.30 | $68.8K | |
| Dec 18, 2019 | Robert L. Van Nostrand | Executive | Option Exercise | 20,000 | $3.28 | $65.6K | |
| Nov 14, 2019 | S. Fisherman Jason | Executive | Option Exercise | 20,000 | $3.28 | $65.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 262 | $330.9M | 59.3% |
Other(J) | 46 | $89.0M | 16.0% |
Purchase(P) | 100 | $80.1M | 14.4% |
Disposition(D) | 11 | $23.4M | 4.2% |
Exercise(M) | 98 | $15.9M | 2.8% |
Exercise (Options)(X) | 2 | $9.9M | 1.8% |
Payment(F) | 2 | $8.7M | 1.6% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Conversion(C) | 17 | $0 | 0.0% |
Insider selling pressure at ACHILLION PHARMACEUTICALS INC has increased, with 54 insiders executing 539 transactions across all time. Total sales of $330.9M significantly outpace purchases of $80.1M, resulting in a net outflow of $250.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.